Humphries William D. Insider Trades

Insider Trading History

Track insider trading activity for Humphries William D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $158k 33,525 shares
Last Trade
Jun 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.33k 4,793 shares
$1.53
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $0 0 shares
Last Trade
Jun 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.33k 4,793 shares
$1.53
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $199k 42,350 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.1k 42,350 shares
$1.56
$4.71
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $18.5k 45,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.8k 45,000 shares
$1.15
$0.41
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $74.2k 15,750 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.2k 15,750 shares
$1.03
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.8k 4,660 shares
$1.03
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $135k 28,732 shares
Last Trade
Jun 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.8k 4,660 shares
$1.03
$4.71
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $0 0 shares
Last Trade
Sep 22, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.5k 22,727 shares
$0.86
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $20.9k 51,040 shares
Last Trade
Sep 22, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.5k 22,727 shares
$0.86
$0.41
STRATA Skin Sciences
STRATA Skin Sciences SSKN
Director
Holding Value $11.9k 109,724 shares
Last Trade
Jul 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.1k 36,408 shares
$0.91
$0.11
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.3k 30,000 shares
$1.31
$0.41
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $113k 24,072 shares
Last Trade
Jun 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.6k 4,507 shares
$8.79
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $0 0 shares
Last Trade
Jun 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.6k 4,507 shares
$8.79
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $74.2k 15,750 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 15,750 shares
$8.70
$4.71
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178 2,538 shares
$0.07
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $178 2,538 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178 2,538 shares
$0.07
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.6k 30,000 shares
$1.62
$0.41
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $74.2k 15,750 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 15,750 shares
$14.48
$4.71
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Director
Holding Value $92.2k 19,565 shares
Last Trade
Jun 02, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.6k 3,356 shares
$14.48
$4.71
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $263 3,750 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16k 3,750 shares
$0.84
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up